Logo image
Sign in
Back
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design
Journal article   Open access   Peer reviewed

Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design

Tadej Battelino, Zsolt Bosnyak, Thomas Danne, Bhaswati Mukherjee, Steve Edelman, Valerie Pilorget, Pratik Choudhary, Eric Renard and Richard Bergenstal
Diabetes Therapy
08/2020
DOI: https://doi.org/10.1007/s13300-020-00853-7
PMCID: PMC7376792
PMID: 32578133

Abstract

Continuous glucose monitoring Fasting plasma glucose Glucose variability Glycated haemoglobin Insulin Insulin degludec Insulin glargine Self-monitoring of plasma glucose Time-in-range Type 1 diabetes
In the original publication, the timing of baseline CGM assessment was incorrectly stated.
url
Find in HALView
url
https://doi.org/10.1007/s13300-020-00853-7View
Published (Version of record) Open

Metrics

1 Record Views

Details

Logo image